Carboxymethylated Desmodium styracifolium polysaccharide reduces the risk of calcium oxalate kidney stone formation by inhibiting crystal adhesion and promoting crystal endocytosis
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Zhi Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changs…. Hauptthemen laut MEDLINE: Calcium Oxalate, Endocytosis, Kidney Calculi, Polysaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Project of Hunan Provincial Health Commission, Clinical Research Center For Pediatric Genitourinary Disease In Hunan Province.
Abstract (Originalsprache)
The inhibition of cell surface crystal adhesion and an appropriate increase in crystal endocytosis contribute to the inhibition of kidney stone formation. In this study, we investigated the effects of different degrees of carboxymethylation on these processes. An injury model was established by treating human renal proximal tubular epithelial (HK‐2) cells with 98.3 ± 8.1 nm calcium oxalate dihydrate (nanoCOD) crystals. The HK‐2 cells were protected with carboxy (‐COOH) Desmodium styracifolium polysaccharides at 1.17% (DSP0), 7.45% (CDSP1), 12.2% (CDSP2), and 17.7% (CDSP3). Changes in biochemical indexes and effects on nanoCOD adhesion and endocytosis were detected. The protection of HK‐2 cells from nanoCOD‐induced oxidative damage by carboxymethylated Desmodium styracifolium polysaccharides (CDSPs) is closely related to the protection of subcellular organelles, such as mitochondria. CDSPs can reduce crystal adhesion on the cell surface and maintain appropriate crystal endocytosis, thereby reducing the risk of kidney stone formation. CDSP2 with moderate ‐COOH content showed the strongest protective activity among the CDSPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, the Affiliated Children's Hospital of Xiangya School of Medicine, Central South University (Hunan Children's Hospital), Changsha, China.
- Institute of Biomineralization and Lithiasis Research, College of Chemistry and Materials Science, Jinan University, Guangzhou, China.
ORCID-Profile: Xin-Yi Tong, Jian-Ming Ouyang
Förderung
- National Natural Science Foundation of China
- Scientific Research Project of Hunan Provincial Health Commission
- Clinical Research Center For Pediatric Genitourinary Disease In Hunan Province
Zitieren
APA
Wang, Z., Liu, L., Zhao, Y. W., Tong, X. Y., Tang, G. H., & Ouyang, J. M. (2024). Carboxymethylated Desmodium styracifolium polysaccharide reduces the risk of calcium oxalate kidney stone formation by inhibiting crystal adhesion and promoting crystal endocytosis. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31272
Vancouver
Wang Z, Liu L, Zhao YW, Tong XY, Tang GH, Ouyang JM. Carboxymethylated Desmodium styracifolium polysaccharide reduces the risk of calcium oxalate kidney stone formation by inhibiting crystal adhesion and promoting crystal endocytosis. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31272
BibTeX
@article{Wang2024,
author = {Wang, Zhi and Liu, Li and Zhao, Yao-Wang and Tong, Xin-Yi and Tang, Gu-Hua and Ouyang, Jian-Ming},
title = {Carboxymethylated Desmodium styracifolium polysaccharide reduces the risk of calcium oxalate kidney stone formation by inhibiting crystal adhesion and promoting crystal endocytosis},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31272}
}
EUVIMED